Envestnet Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$181M Buy
468,145
+28,647
+7% +$10.6M 0.04% 389
2026
Q1
$129M Buy
439,498
+14,216
+3% +$4.67M 0.03% 452
2025
Q4
$149M Sell
425,282
-48,742
-10% -$16.5M 0.04% 379
2025
Q3
$153M Sell
474,024
-48,990
-9% -$15.2M 0.04% 383
2025
Q2
$203M Sell
523,014
-50,593
-9% -$20.3M 0.06% 303
2025
Q1
$249M Buy
573,607
+82,014
+17% +$32.9M 0.08% 238
2024
Q4
$181M Sell
491,593
-84,362
-15% -$35.3M 0.06% 310
2024
Q3
$299M Buy
575,955
+21,365
+4% +$11.4M 0.1% 190
2024
Q2
$301M Buy
554,590
+26,222
+5% +$13.9M 0.1% 174
2024
Q1
$274M Buy
528,368
+47,050
+10% +$23.4M 0.1% 193
2023
Q4
$227M Buy
481,318
+18,740
+4% +$8.67M 0.09% 203
2023
Q3
$201M Buy
462,578
+115,044
+33% +$52.2M 0.09% 205
2023
Q2
$154M Sell
347,534
-2,618,671
-88% -$1.21B 0.07% 246
2023
Q1
$148M Buy
2,966,205
+2,651,986
+844% +$1.26B 0.07% 243
2022
Q4
$161M Buy
314,219
+18,005
+6% +$9.14M 0.08% 215
2022
Q3
$135M Buy
296,214
+15,438
+5% +$7.39M 0.08% 218
2022
Q2
$135M Buy
280,776
+2,700
+1% +$1.34M 0.08% 226
2022
Q1
$137M Buy
278,076
+6,554
+2% +$3M 0.07% 248
2021
Q4
$126M Buy
271,522
+11,694
+5% +$4.92M 0.06% 262
2021
Q3
$96.9M Sell
259,828
-12,521
-5% -$4.76M 0.05% 298
2021
Q2
$104M Buy
272,349
+3,051
+1% +$1.17M 0.06% 266
2021
Q1
$96.7M Buy
269,298
+136,885
+103% +$44M 0.06% 253
2020
Q4
$42.5M Buy
132,413
+18,014
+16% +$5.53M 0.03% 390
2020
Q3
$30.7M Sell
114,399
-4,170
-4% -$1.12M 0.03% 423
2020
Q2
$31.2M Buy
118,569
+6,564
+6% +$1.75M 0.03% 396
2020
Q1
$25.4M Buy
112,005
+17,313
+18% +$4.72M 0.03% 386
2019
Q4
$28.6M Sell
94,692
-22,032
-19% -$6.06M 0.03% 415
2019
Q3
$28M Sell
116,724
-723
-0.6% -$198K 0.03% 391
2019
Q2
$33.1M Buy
117,447
+21,166
+22% +$5.78M 0.04% 318
2019
Q1
$27.6M Buy
96,281
+33,042
+52% +$9.56M 0.04% 347
2018
Q4
$16.6M Buy
63,239
+61,685
+3,969% +$17M 0.03% 434
2018
Q3
$426K Sell
1,554
-7,112
-82% -$1.85M ﹤0.01% 963
2018
Q2
$2.06M Sell
8,666
-1,124
-11% -$260K ﹤0.01% 798
2018
Q1
$2.17M Sell
9,790
-11,956
-55% -$2.81M 0.01% 679
2017
Q4
$4.89M Sell
21,746
-1,129
-5% -$240K 0.01% 610
2017
Q3
$4.34M Sell
22,875
-1,742
-7% -$332K 0.01% 607
2017
Q2
$4.63M Buy
24,617
+4,977
+25% +$894K 0.01% 597
2017
Q1
$3.24M Buy
19,640
+2,611
+15% +$415K 0.01% 733
2016
Q4
$2.45M Buy
17,029
+7,633
+81% +$1.02M 0.01% 837
2016
Q3
$1.18M Sell
9,396
-16,677
-64% -$2.15M ﹤0.01% 1173
2016
Q2
$3.42M Sell
26,073
-6,164
-19% -$843K 0.01% 790
2016
Q1
$4.48M Sell
32,237
-8,993
-22% -$1.2M 0.02% 640
2015
Q4
$5.75M Buy
41,230
+5,703
+16% +$786K 0.03% 522
2015
Q3
$4.97M Sell
35,527
-6,882
-16% -$1.03M 0.02% 558
2015
Q2
$6.96M Buy
+42,409
New +$6.78M 0.03% 482
2014
Q4
Sell
-1,128
Closed -$135K 2549
2014
Q3
$135K Buy
1,128
+478
+74% +$54.8K ﹤0.01% 1208
2014
Q2
$70K Sell
650
-112
-15% -$11.5K ﹤0.01% 1327
2014
Q1
$76K Sell
762
-474
-38% -$42.9K ﹤0.01% 1225
2013
Q4
$114K Sell
1,236
-524
-30% -$46.6K ﹤0.01% 979
2013
Q3
$147K Buy
1,760
+839
+91% +$71.9K ﹤0.01% 865
2013
Q2
$75K Buy
+921
New +$68.9K ﹤0.01% 1073

Other funds holding ELV

Envestnet Asset Management's ELV Position: Q2 2026 in Review

Envestnet Asset Management increased its Elevance Health (ELV) stake by 6.5% in Q2 2026, buying an estimated $10.6M and bringing the position to 468,145 shares worth $181M. The position accounts for 0.04% of the portfolio, ranked #389.

Envestnet Asset Management first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $301M in Q2 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Envestnet Asset Management held 468,145 shares of Elevance Health worth $181M as of Q2 2026.
  • Envestnet Asset Management bought 28,647 Elevance Health shares in Q2 2026, an estimated $10.6M.
  • Elevance Health made up 0.04% of Envestnet Asset Management's portfolio in Q2 2026, its #389 holding.
  • Envestnet Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • Envestnet Asset Management's Elevance Health position peaked at $301M in Q2 2024.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.